Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Breast cancer is the most commonly occurring cancer in women. There were over two-million new cases in world in 2018. It is the second leading cause of death from cancer in western countries. At the molecular level, breast cancer is a heterogeneous disease, which is characterized by high genomic ins...
Main Authors: | Ugo Testa, Germana Castelli, Elvira Pelosi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3271/8/1/18 |
Similar Items
-
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets
by: Ugo Testa, et al.
Published: (2020-07-01) -
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
by: Ugo Testa, et al.
Published: (2018-07-01) -
Screening and Identification of Key Common and Specific Genes and Their Prognostic Roles in Different Molecular Subtypes of Breast Cancer
by: Na Sun, et al.
Published: (2021-02-01) -
Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer
by: Chia-Jung Li, et al.
Published: (2021-06-01) -
Screening of immunosuppressive factors for biomarkers of breast cancer malignancy phenotypes and subtype-specific targeted therapy
by: Ping Wang, et al.
Published: (2019-06-01)